Patents Assigned to SANTA CRUZ PHARMACEUTICALS, INC.
  • Publication number: 20190388341
    Abstract: The invention provides a chewable gel dosage form that contains at least one active agent and a method of administering such chewable gel dosage form to subjects to treat one or more indications associated with the active agent(s). In one embodiment, the invention provides a method for the temporary relief of symptoms to due hay fever and upper respiratory allergies comprising administering to a subject in need thereof a chewable gel dosage form comprising a therapeutically effective amount of loratadine and a gelling agent, wherein therapeutic efficacy is achieved under fasted or fed conditions.
    Type: Application
    Filed: April 1, 2019
    Publication date: December 26, 2019
    Applicant: Santa Cruz Pharmaceuticals. Inc.
    Inventors: Michael A. SIMPSON, Benoit MINVILLE, William BOST, Alain CARRIER
  • Publication number: 20170209369
    Abstract: The invention provides a semi-solid chewable dosage form that contains one or more active pharmaceutical ingredients that are generally available as over-the-counter medications including, for example, chlorpheniramine maleate, phenylephrine hydrochloride, guaifenesin, dextromethorphan hydrobromide, loratadine, or a combination thereof. The invention further provides a semi-solid chewable dosage form that contains chlorpheniramine maleate, phenylephrine hydrochloride or a combination thereof, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention further provides a semi-solid chewable dosage form that contains the active pharmaceutical ingredient chlorpheniramine maleate, phenylephrine hydrochloride or a combination thereof, a gelling agent, gelatin, sugar, corn syrup, and a pH adjusting agent. The semi-solid chewable dosage form is useful for administration to individuals to treat symptoms from allergies, colds, congestion, and the like.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Applicant: Santa Cruz Pharmaceuticals, Inc.
    Inventors: Michael T. WESTHUSING, Yong BAI, Mario W. MEDRI
  • Publication number: 20170209370
    Abstract: The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Applicant: Santa Cruz Pharmaceuticals, Inc.
    Inventors: Michael T. WESTHUSING, Yong BAI, Mario W. MEDRI
  • Publication number: 20160151279
    Abstract: The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent.
    Type: Application
    Filed: February 8, 2016
    Publication date: June 2, 2016
    Applicant: SANTA CRUZ PHARMACEUTICALS, INC.
    Inventors: Michael WESTHUSING, Yong BAI, Mario W. MEDRI
  • Publication number: 20160067180
    Abstract: The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Applicant: SANTA CRUZ PHARMACEUTICALS, INC.
    Inventors: Michael T. WESTHUSING, Yong BAI, Mario W. MEDRI